Charles River (CRL) executive Parisotto exercises options, sells 3,714 shares under 10b5-1 plan
Rhea-AI Filing Summary
Charles River Laboratories International executive Shannon M. Parisotto, CEVP, Discovery & Safety Assessment, exercised stock options for 3,714 shares of common stock at an exercise price of $179.66 per share on 2026-08-11 and sold the same 3,714 shares at $279.66 per share. The exercise and sale were carried out pursuant to a Rule 10b5-1 Trading Plan initially adopted on March 4, 2026. Following these transactions, reported indirect holdings include 9,680 shares held by a trust and 28,510 shares held by Karpathos Investments LLC.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 3,714 shares ($371K approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Parisotto Shannon M
Role
CEVP, Disc & Safety Assessment
Sold
3,714 shs ($1.04M)
Approx. gross sale proceeds
$1.04M
Approx. exercise cost
$667K
Approx. pre-tax spread
$371K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 3,714 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,714 | $179.66 | $667K |
| Sale | Common Stock F1 | 3,714 | $279.66 | $1.04M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 0 shares (Direct);
Common Stock — 4,807 shares (Direct);
Common Stock — 9,680 shares (Indirect, By Trust);
Common Stock — 28,510 shares (Indirect, by Karpathos Investments LLC)
Footnotes (1)
- F1. This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026.
Key Figures
Options Exercised: 3,714 shares
Option Exercise Price: $179.66 per share
Shares Sold: 3,714 shares
+5 more
8 metrics
Options Exercised
3,714 shares
Stock options exercised into common stock on 2026-08-11
Option Exercise Price
$179.66 per share
Exercise price for 3,714 stock options
Shares Sold
3,714 shares
Common stock sold on 2026-08-11
Sale Price
$279.66 per share
Per-share price for 3,714 common shares sold
Indirect Holdings by Trust
9,680 shares
Common stock held indirectly "By Trust" after transactions
Indirect Holdings by Karpathos Investments LLC
28,510 shares
Common stock held indirectly through Karpathos Investments LLC
Option Expiration Date
2030-05-29
Expiration date of exercised stock options
10b5-1 Plan Adoption Date
March 4, 2026
Initial adoption date of Rule 10b5-1 Trading Plan covering the trades
Key Terms
Rule 10b5-1 Trading Plan, Stock Options (Right to Buy), indirect, open market or private transaction
4 terms
Rule 10b5-1 Trading Plan regulatory
"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
indirect financial
"ownership_type: indirect, nature_of_ownership: By Trust"
open market or private transaction financial
"transaction_code_description: Sale in open market or private transaction"
FAQ
What did CRL executive Shannon M. Parisotto report on this Form 4?
Shannon M. Parisotto reported exercising options for 3,714 CRL shares at $179.66 and selling 3,714 shares at $279.66 on 2026-08-11, under a pre-established Rule 10b5-1 trading plan.
What options did Parisotto exercise in this CRL Form 4 filing?
Parisotto exercised stock options for 3,714 shares of CRL common stock with an exercise price of $179.66 per share. These options had an exercise date of 2021-05-29 and an expiration date of 2030-05-29.
Was the CRL insider transaction by Parisotto under a Rule 10b5-1 plan?
Yes. The filing notes the exercise and sale occurred under a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026, indicating the trades were pre-arranged.
What are Parisotto’s remaining indirect CRL holdings after these transactions?
Indirectly, Parisotto reports 9,680 CRL shares held "By Trust" and 28,510 shares held by Karpathos Investments LLC. These figures reflect indirect ownership positions following the reported 2026-08-11 transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
